Annual report pursuant to Section 13 and 15(d)

SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.22.1
SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Jan. 17, 2019
Marketed and commercialized $ 47,980    
Grant receivable $ 56,359 $ 224,879  
Ownership percentage 50.00%    
Deferred revenue recognized $ 34,980    
Allowance for doubtful accounts 0 0  
Impairment of assets 141,480 0  
Grant funding during the first year     $ 2,842,430
Grant funding during the third year     3,453,367
Grant funding during the second year     $ 2,831,838
Advertising costs 426,917 443,175  
Research and development expenses 1,605,907 4,273,815  
Deferred income 0 65,560  
Grant income $ 835,924 $ 4,464,626  
Royalty obligations description   The Company accounted for royalty obligations as debt in accordance with ASC 470-10-25 and derived a debt discount, which is amortized using the effective interest method over the expected life of the arrangement, which is 15 years. The Company has no obligation to repay the then outstanding balance if during the expected life of 15 years the treatment is discontinued  
Royalty obligations, net   $ 7,171,200  
Minimum [Member]      
Property plant and equipment estimated useful lives   5 years  
Maximum [Member]      
Property plant and equipment estimated useful lives   15 years